Antonio P. Arenas‐de Larriva

Long-term consumption of a mediterranean diet or a low-fat diet on kidney function in coronary heart disease patients: The CORDIOPREV randomized controlled trial

Alicia Podadera-Herreros, Juan F. Alcalá‐Díaz, Francisco M. Gutierrez‐Mariscal et al. · Clinical Nutrition · 2022 · 77 citations · Full text

Medicine, Cardiology, Nutritional Sciences +13

Mediterranean diet as a strategy for preserving kidney function in patients with coronary heart disease with type 2 diabetes and obesity: a secondary analysis of CORDIOPREV randomized controlled trial

Alicia Podadera-Herreros, Antonio P. Arenas‐de Larriva, Francisco M. Gutierrez‐Mariscal et al. · Nutrition and Diabetes · 2024 · 25 citations · Full text

Medicine, Endocrinology, Nephrology +17

Oral intake of Lactiplantibacillus pentosus LPG1 Produces a Beneficial Regulation of Gut Microbiota in Healthy Persons: A Randomised, Placebo-Controlled, Single-Blind Trial

Elio López‐García, Antonio Benítez‐Cabello, Antonio P. Arenas‐de Larriva et al. · Nutrients · 2023 · 22 citations · Full text

Life Sciences, Microbiology, Nutritional Sciences +17

A microbiota pattern associated with cardiovascular events in secondary prevention: the CORDIOPREV study

Javier Arenas‐Montes, Juan F. Alcalá‐Díaz, Helena García-Fernández et al. · European Heart Journal · 2025 · 20 citations

Life Sciences, Cardiology, Microbiology +17

Metabolomics analysis of type 2 diabetes remission identifies 12 metabolites with predictive capacity: a CORDIOPREV clinical trial study

Marina Mora-Ortiz, Juan F. Alcalá‐Díaz, Oriol Alberto Rangel-Zúñiga et al. · BMC Medicine · 2022 · 16 citations · Full text

Life Sciences, Biochemistry, Diabetology +16